ArticleOncotarget2017

Generation and characterization of ErbB2-CAR-engineered cytokine-induced killer cells for the treatment of high-risk soft tissue sarcoma in children.

Michael Merker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.